Chronic Administration of Adrenomedullin Attenuates Transition From Left Ventricular Hypertrophy to Heart Failure in Rats
Toshio Nishikimi(Kyoto University), Hiroaki Matsuoka(Social Welfare Department), Shigeo Horinaka(Dokkyo University), Fumiki Yoshihara(National Cerebral and Cardiovascular Center), Naohiko Kobayashi(Dokkyo University), Kazumi Akimoto(Dokkyo University), Yosuke Mori(Dokkyo Medical University), Kazuyoshi Tadokoro(Dokkyo Medical University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Naoto Minamino(National Cerebral and Cardiovascular Center)
Cited by 61
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307